MeSH Review:
Motion Sickness
- Towards understanding the aetiology and pathophysiology of the emetic reflex: novel approaches to antiemetic drugs. Bountra, C., Gale, J.D., Gardner, C.J., Jordan, C.C., Kilpatrick, G.J., Twissell, D.J., Ward, P. Oncology (1996)
- Effect of ondansetron on nausea and vomiting after middle ear surgery during general anaesthesia. Honkavaara, P. British journal of anaesthesia. (1996)
- Effects of histamine and betahistine on rat medial vestibular nucleus neurones: possible mechanism of action of anti-histaminergic drugs in vertigo and motion sickness. Wang, J.J., Dutia, M.B. Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale. (1995)
- Neurological disorders and travel. Awada, A., Kojan, S. Int. J. Antimicrob. Agents (2003)
- Effects of dimenhydrinate on gastric tachyarrhythmia and symptoms of vection-induced motion sickness. Muth, E.R., Jokerst, M., Stern, R.M., Koch, K.L. Aviation, space, and environmental medicine. (1995)
- Impaired gastric slow waves induced by spatial disorientation and effect of domperidone. Kono, T., Tokumaru, O., Mizumoto, C., Tatsuno, J., Chen, J.D. Am. J. Gastroenterol. (1999)
- Autogenic-feedback training exercise is superior to promethazine for control of motion sickness symptoms. Cowings, P.S., Toscano, W.B. Journal of clinical pharmacology. (2000)
- Effect of tryptophan depletion on symptoms of motion sickness in migraineurs. Drummond, P.D. Neurology (2005)
- Vestibular, central and gastral triggering of emesis. A study on individual susceptibility in rats. Hasegawa, S., Takeda, N., Morita, M., Horii, A., Koizuka, I., Kubo, T., Matsunaga, T. Acta Otolaryngol. (1992)
- A systematic review of the applicability and efficacy of eye exercises. Rawstron, J.A., Burley, C.D., Elder, M.J. Journal of pediatric ophthalmology and strabismus. (2005)
- Transderm Scop for prevention of motion sickness. Johnson, P., Hansen, D., Matarazzo, D., Petterson, L., Swisher, C., Trappolini, A. N. Engl. J. Med. (1984)
- Alleviation of motion sickness by nifedipine. Marley, J.E., Joy, M.D. Lancet (1987)
- Pharmacology in space. Part 2. Controlling motion sickness. Lathers, C.M., Charles, J.B., Bungo, M.W. Trends Pharmacol. Sci. (1989)
- Cinnarizine in the prophylaxis of seasickness: laboratory vestibular evaluation and sea study. Shupak, A., Doweck, I., Gordon, C.R., Spitzer, O. Clin. Pharmacol. Ther. (1994)
- Transdermal scopolamine, oral meclizine, and placebo in motion sickness. Dahl, E., Offer-Ohlsen, D., Lillevold, P.E., Sandvik, L. Clin. Pharmacol. Ther. (1984)
- Transdermal scopolamine in the prevention of motion sickness at sea. Price, N.M., Schmitt, L.G., McGuire, J., Shaw, J.E., Trobough, G. Clin. Pharmacol. Ther. (1981)
- Pharmacological agents affecting emesis. A review (Part II). Mitchelson, F. Drugs (1992)
- Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Clissold, S.P., Heel, R.C. Drugs (1985)
- Motion sickness potentiates core cooling during immersion in humans. Mekjavic, I.B., Tipton, M.J., Gennser, M., Eiken, O. J. Physiol. (Lond.) (2001)
- Motion sickness--key to neurobiologic variation. Mirabile, C.S., Glueck, B.C. The Journal of clinical psychiatry. (1979)
- Preclinical studies on LY228729: a potent and selective serotonin1A agonist. Foreman, M.M., Fuller, R.W., Leander, J.D., Benvenga, M.J., Wong, D.T., Nelson, D.L., Calligaro, D.O., Swanson, S.P., Lucot, J.B., Flaugh, M.E. J. Pharmacol. Exp. Ther. (1993)
- Phenytoin for motion sickness: clinical evaluation. Knox, G.W., Woodard, D., Chelen, W., Ferguson, R., Johnson, L. Laryngoscope (1994)
- Histamine and related substances influence neurotransmission in the semicircular canal. Housley, G.D., Norris, C.H., Guth, P.S. Hear. Res. (1988)
- Catecholaminergic responses to rotational stress in rat brain stem: implications for amphetamine therapy of motion sickness. Takeda, N., Morita, M., Yamatodani, A., Wada, H., Matsunaga, T. Aviation, space, and environmental medicine. (1990)
- Histaminergic mechanism of motion sickness. Neurochemical and neuropharmacological studies in rats. Takeda, N., Morita, M., Kubo, T., Yamatodani, A., Watanabe, T., Wada, H., Matsunaga, T. Acta Otolaryngol. (1986)
- Area postrema lesions in rats enhance the magnitude of body rotation-induced conditioned taste aversions. Ossenkopp, K.P. Behavioral and neural biology. (1983)
- Mode of action of gingerols and shogaols on 5-HT3 receptors: binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum. Abdel-Aziz, H., Windeck, T., Ploch, M., Verspohl, E.J. Eur. J. Pharmacol. (2006)
- beta-Endorphin and arginine vasopressin following stressful sensory stimuli in man. Kohl, R.L. Aviation, space, and environmental medicine. (1992)
- Increased secretion of growth hormone, prolactin, antidiuretic hormone, and cortisol induced by the stress of motion sickness. Eversmann, T., Gottsmann, M., Uhlich, E., Ulbrecht, G., von Werder, K., Scriba, P.C. Aviation, space, and environmental medicine. (1978)
- Hormonal changes after parabolic flight: implications on the development of motion sickness. Drummer, C., Stromeyer, H., Riepl, R.L., König, A., Strollo, F., Lang, R.E., Maass, H., Röcker, L., Gerzer, R. Aviation, space, and environmental medicine. (1990)
- Comparison of granisetron, droperidol, and metoclopramide for prevention of postoperative vomiting in children with a history of motion sickness undergoing tonsillectomy. Fujii, Y., Tanaka, H. J. Pediatr. Surg. (2001)
- Suncus murinus as a new experimental model for motion sickness. Ueno, S., Matsuki, N., Saito, H. Life Sci. (1988)
- Prophylactic ondansetron for post-operative emesis: meta-analysis of its effectiveness in patients with and without a previous history of motion sickness. Figueredo, E., Canosa, L. European journal of anaesthesiology. (1999)